Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 31Unknown 8Terminated 8Recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

Timolol 1Ointments 1Mupirocin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Hemangioma × Clear all
NCT00974129 2014-06-24

A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas

Yale University

Withdrawn

Hemangioma

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡